Jafary Hanieh

Dr. Jafary Hanieh


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2019 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
AMAli Morovati
Ali Morovati
SAShahin Ahmadian
Shahin Ahmadian
JHJafary Hanieh
Jafary Hanieh


3 June 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
NSNafiseh Shafiei
Nafiseh Shafiei
HHHamideh Mahmoodzadeh Hosseini
Hamideh Mahmoodzadeh Hosseini
JAJafar Amani
Jafar Amani
SMSeyed Ali Mirhosseini
Seyed Ali Mirhosseini
JHJafary Hanieh
Jafary Hanieh


10 October 2022 in Research Square
Verified
Preprint
Open access
PDF file
FBFatemeh Barekat
Fatemeh Barekat
JHJafary Hanieh
Jafary Hanieh
MGMaryam Ghobeh
Maryam Ghobeh
Glioblastoma is the most prevalent primary brain tumor with survival rate of about 20.5 months. Hence, investigation on the involved signaling pathways to treat the disease is urgently needed. CD73 and adenosine play key roles in tumor invasion, proliferation, angiogenesis, and chemical resistance of cancer cells. Theophylline are known as adenosine A2a receptor antagonists. Current study investigates the plausible impacts of theophylline in the mice model of glioblastoma. Materials and Methods: Initially, induction of glioblastoma tumor was performed within 10 days in male Balb/ C mice. Next, the mice were treated with theophylline for 14 days. Garcia's behavioral test was performed. Moreover, histopathological changes in brain tissue were examined using hematoxylin and eosin staining. The expression of A2a and CD73 proteins was assessed by western blotting. Additionally, the expression of VEGF was indicated by immunohistochemistry. Apoptosis was examined by the TUNEL method. Finally, serum levels of MDA and SOD were investigated using the ELISA method. Results: Garcia's behavioral test indicated a reduction in behavioral and cognitive impairments in theophylline-treated mice. Pathological results demonstrated decreased tumor size and angiogenesis in treatment group. The presence of A2a and CD73 proteins were lower in the treated mice. Moreover, immunohistochemistry investigations showed a decline in VEGF expression in brain tissue and angiogenesis in the theophylline-treated group compared to the control group. Finally, serum levels of MDA and SOD were reduced in theophylline-treated mice. Conclusion: Theophylline seem to ameliorate glioblastoma cancer by improving CD73 or adenosine signaling.